"The Cost of Being Excluded: Impact of Excluded Medications under Medicare Part D on Dually Eligible Nursing Home Residents," University of the Sciences in Philadelphia/American Society of Consultant Pharmacists: The report by Richard Stefanacci, a CMS health policy scholar from 2003 to 2004 and founding executive director of the university's Health Policy Institute, examines the access-to-care issues that could result from the end of Medicaid drug benefits for dually eligible beneficiaries once Medicare drug coverage takes effect. The paper specifically discusses the limitations of the Medicare drug benefit, which will not cover all classes of drugs that beneficiaries might need (Stefanacci, "The Cost of Being Excluded: Impact of Excluded Medications under Medicare Part D on Dually Eligible Nursing Home Residents," 2/16).